HRT Solution (rev. edition): Optimizing Your Hormonal Potential: Newly Revised with All the Latest Information (Avery Health Guides)

MARLA AHLGRIMM, R.PH., is the founder and chair of Women's Health America (WHA) Group and cofounder of Madison Pharmacy Associates, Inc., the first pharmacy in the United States devoted entirely to women's health care. Ms. Ahlgrimm was one of the first health professionals in the United States to recognize, define, and develop treatment options for premenstrual syndrome (PMS). 

JOHN M. KELLS is the cofounder and chief executive of Aeron LifeCycles Clinical Laboratory, a leader in research on the impact of hormones on breast cancer and women's health. 

CHRISTINE MacGENN RODGERSON is a writer and editor who specializes in scientific, health, and medical issues.

Now revised and updated, the comprehensive program for restoring vitality, sexuality, and health using natural hormones—just the ones each individual woman needs, and just the amount she needs. 

The decision of whether or not to use hormone replacement therapy (HRT) during menopause is perhaps more controversial—and more confusing—than ever before. The HRT Solution provides a balanced discussion of the issues and, most important, offers a choice that goes beyond "yes" or "no." 

The authors explain the shortcomings of the conventional, "cookie-cutter" approach to HRT, which gives women standardized amounts of synthetic hormone substitutes or animal-derived hormone products. Instead, they recommend a program designed to meet each woman's particular needs. Their approach emphasizes the importance of testing and ongoing monitoring to determine precisely which hormones a woman may want to supplement. The solution lies in the prescription of individualized doses of custom-made natural hormones—exact matches for the ones a woman's body produces. The HRT Solution makes it possible for each woman to maintain a hormonal balance that is optimal for her body and her well-being, without the unpleasant side effects and potential for long-term health problems associated with conventional HRT.